English
Back
Download
Log in to access Online Inquiry
Back to the Top

Update

$Gain Therapeutics (GANX.US)$ Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson's Disease
2 MINUTES AGO, 7:30 AM EDT
VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
4
Translate
Report
6127 Views
Comment
Sign in to post a comment
5231
Followers
23
Following
75K
Visitors
Follow
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.